 |
 |
|
|
RESÚMENES JULIO 2005 |
Psychotic Disorders & Antipsychotics
(Requiere estar conectado a internet. Haga un click en la
información del journal)
The impact of substance use disorders on clinical outcome in 643
patients with first-episode psychosis
M. Lambert, P. Conus, D. I. Lubman, D. Wade, H.
Yuen, S. Moritz, D. Naber, P. D. McGorry, B. G. Schimmelmann
Acta Psychiatrica Scandinavica. Volume 112 Issue
2 Page 141 - August 2005
Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study
Ping Qin, Huilan Xu, Thomas Munk Laursen, Mogens Vestergaard, Preben Bo Mortensen
KEITH HAWTON, LESLEY SUTTON, CAMILLA HAW, JULIA SINCLAIR, JONATHAN J.
DEEKS
The British Journal of Psychiatry (2005) 187: 9-20
SEAN A. SPENCE, RUSSELL D. GREEN, IAIN D. WILKINSON, MIKE D. HUNTER
The British Journal of Psychiatry (2005) 187: 55-61
Attitudes Toward Antipsychotic Medication. The Impact of
Clinical Variables and Relationships With Health Professionals
Jennifer
C. Day, Richard P. Bentall, Chris Roberts, Fiona Randall, Anne Rogers, Dinah
Cattell, David Healy, Pam Rae, Cheryl Power
Arch Gen Psychiatry. 2005;62:717-724
Quality of Life in Schizophrenia: A Multicenter, Randomized, Naturalistic, Controlled Trial Comparing Olanzapine to First-Generation Antipsychotics
Maurício Silva de
Lima, Jair de Jesus Mari, Alan Breier, Anna Maria Costa, Eduardo Pondé de Sena,
and Matthew Hotopf
J Clin Psychiatry 2005;66:831-838
Chang Yoon Kim,
Yong-Wook Shin, Yeon Ho Joo, Jin-Pyo Hong, Gun Hee Lee, and Sung-Ku Choi
J Clin Psychiatry 2005;66:887-893
Diabetes Mellitus Among Outpatients Receiving Clozapine: Prevalence and Clinical-Demographic Correlates
J. Steven Lamberti,
G. Oana Costea, David Olson, John F. Crilly, Kumar Maharaj, Xin Tu, Adrienne
Groman, Marci B. Dietz, Margaret P. Bushey, Telva Olivares, and Karen Wiener
J Clin Psychiatry 2005;66:900-906
Schizophrenia and
depression: Challenging the paradigm of two separate diseases—A controlled
study of schizophrenia, depression and healthy controls
Heinz Häfner, Kurt
Maurer, Günter Trendler, Wolfram an der Heiden, Martin Schmidt and Regina
Könnecke
Schizophrenia
Research. Volume 77, Issue 1, 1 September 2005, Pages 11-24
Trends in the
pharmacological treatment of patients with schizophrenia over a 12 year
observation period
Monika Edlinger,
Armand Hausmann, Georg Kemmler, Martin Kurz, Ilsemarie Kurzthaler, Thomas
Walch, Michaela Walpoth and W. Wolfgang Fleischhacker
Schizophrenia
Research. Volume 77, Issue 1, 1 September 2005, Pages 25-34
Increased
prevalence of schizophrenia spectrum disorders in relatives of
neuroleptic-nonresponsive schizophrenic patients
Ridha Joober, Guy
A. Rouleau, Samarthji Lal, David Bloom, Pierre Lalonde, Alain Labelle and
Chawki Benkelfat
Schizophrenia
Research. Volume 77, Issue 1, 1 September 2005, Pages 35-41
Wulf Rössler, Hans
Joachim Salize, Jim van Os and Anita Riecher-Rössler
European
Neuropsychopharmacology. Volume 15, Issue 4, August 2005, Pages 399-409
Depression in the long-term course of schizophrenia
Wolfram an
der Heiden, Regina Könnecke, Kurt Maurer, Daniel Ropeter
and Heinz Häfner
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 3: 174 - 184
Antipsychotic and
antidepressive effects of second generation antipsychotics. Two different
pharmacological mechanisms?
Hans-Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 3: 190 - 201
Sleep disturbance in schizophrenia
Jaime
M. Monti and Daniel Monti
International Review of Psychiatry; Volume 17, Number
4 / August 2005: 247 - 253
C. Boudet, M.L.
Bocca, B. Chabot, P. Delamillieure, P. Brazo, P. Denise and S. Dollfus
European
Psychiatry. Volume 20, Issue 4, June 2005, Pages 339-345
Anton Grech, Jim
Van Os, Peter B. Jones, Shon W. Lewis and Robin M. Murray
European
Psychiatry. Volume 20, Issue 4, June 2005, Pages 349-353
Rapid Dose Escalation With Quetiapine: A Pilot Study
Smith, Mark A.; McCoy, Robin;
Hamer-Maansson, Jennifer; Brecher, Martin
Journal
of Clinical Psychopharmacology. 25(4):331-335, August 2005
Patterns
of prescription of four major antipsychotics: a retrospective study based on
medical records of psychiatric inpatients
Gasquet I, Gury C, Tcherny-Lessenot S, Quesnot A, Gaudebout P.
Pharmacoepidemiol Drug Saf. 2005 Jul 13; [Epub ahead
of print]
Cortisol and Cytokines in Chronic and Treatment-Resistant
Patients with Schizophrenia: Association with Psychopathology and Response to
Antipsychotics
Xiang Yang Zhang, Dong Feng Zhou,
Lian Yuan Cao, Gui Ying Wu and Yu Cun Shen
Neuropsychopharmacology (2005) 30, 1532-1538
Wolfgang Aichhorn, Ulrike Weiss, Josef Marksteiner, Georg Kemmler,
Thomas Walch, Gerald Zernig, Renate Stelzig-Schoeler, Christoph Stuppaeck,
Christian Geretsegger
Journal of
Psychopharmacology, Vol. 19, No. 4, 395-401 (2005)
Antipsychotic Polypharmacy: Is There Evidence for its Use?
PATRICK, VIJAYALAKSHMY; LEVIN, ELIZABETH;
SCHLEIFER, STEVEN
Journal of Psychiatric Practice. 11(4):248-257, July
2005
Ghrelin
plasma levels during psychopharmacological treatment.
Himmerich H, Fulda S,
Kunzel HE, Pfennig A, Dzaja A, Cummings DE, Pollmacher T
Neuropsychobiology. 2005;52(1):11-6. Epub 2005 Jun 3
Temporoparietal
Transcranial Magnetic Stimulation for Auditory Hallucinations: Safety, Efficacy
and Moderators in a Fifty Patient Sample
Ralph E. Hoffman,
Ralitza Gueorguieva, Keith A. Hawkins, Maxine Varanko, Nash N. Boutros, Yute
Wu, Kathleen Carroll and John H. Krystal
Biological Psychiatry. Volume 58, Issue 2, 15 July 2005, Pages
97-104
Treatment
Response to Olanzapine and Haloperidol and its Association With Dopamine D2
Receptor Occupancy in First-Episode Psychosis